Toxoplasma gondii is one of the most widely spread parasitic organisms in the world. T. gondii causes primary, chronic infection and mortality. Major surface antigen 1 is the most abundant tachyzoite surface protein and highly conserved between species and causes strong humoural response. Some studies showed that the peptide sequence of surface antigen has immunity. Therefore, tachyzoite surface antigenic peptide sequence is one of the good candidates for vaccine development. However, conformational information and delivery systems are very important parameters for vaccine development. Computational chemistry which is used as an effective method to perform drug or vaccine design provides important information on structure-activity relations...
Toxoplasmosis is a global threat with significant zoonotic concern. The present in silico study was ...
This study aims at developing novel core-shell poly(methylmethacrylate) (PMMA) nanoparticles as a de...
AbstractNovel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic pept...
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed; however, a ...
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed; however, a ...
International audienceAlthough vaccination is a promising approach for the control of toxoplasmosis,...
This study was aimed at designing and evaluation of a multimeric vaccine construct against Toxoplasm...
SummaryBackgroundProtein antigens comprising peptide motifs with high binding affinity to major hist...
The widespread distribution of Toxoplasma gondii (T. gondii) infection and its harsh outcomes in pre...
Rhoptry proteins (ROPs) play a significant role in various stages of Toxoplasma gondii (T. gondii) l...
Background: Protein antigens comprising peptide motifs with high binding affinity to major histocomp...
One third of the world population is infected with Toxoplasma gondii (TG). This obligate intracellul...
Purpose: The Toxoplasma gondii calcium-dependent protein kinase-3 (CDPK3) is a key enzyme for parasi...
The pathogen of toxoplasmosis, Toxoplasma gondii (T. gondii), is a zoonotic protozoon that can affec...
Introduction: This study aimed to evaluate rSAG1-PLGA efficacy as a particulate vaccine in conferrin...
Toxoplasmosis is a global threat with significant zoonotic concern. The present in silico study was ...
This study aims at developing novel core-shell poly(methylmethacrylate) (PMMA) nanoparticles as a de...
AbstractNovel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic pept...
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed; however, a ...
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed; however, a ...
International audienceAlthough vaccination is a promising approach for the control of toxoplasmosis,...
This study was aimed at designing and evaluation of a multimeric vaccine construct against Toxoplasm...
SummaryBackgroundProtein antigens comprising peptide motifs with high binding affinity to major hist...
The widespread distribution of Toxoplasma gondii (T. gondii) infection and its harsh outcomes in pre...
Rhoptry proteins (ROPs) play a significant role in various stages of Toxoplasma gondii (T. gondii) l...
Background: Protein antigens comprising peptide motifs with high binding affinity to major histocomp...
One third of the world population is infected with Toxoplasma gondii (TG). This obligate intracellul...
Purpose: The Toxoplasma gondii calcium-dependent protein kinase-3 (CDPK3) is a key enzyme for parasi...
The pathogen of toxoplasmosis, Toxoplasma gondii (T. gondii), is a zoonotic protozoon that can affec...
Introduction: This study aimed to evaluate rSAG1-PLGA efficacy as a particulate vaccine in conferrin...
Toxoplasmosis is a global threat with significant zoonotic concern. The present in silico study was ...
This study aims at developing novel core-shell poly(methylmethacrylate) (PMMA) nanoparticles as a de...
AbstractNovel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic pept...